GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,637.00p
   
  • Change Today:
    -3.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 735,738
  • Market Cap: £67,852m
  • RiskGrade: 129

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Mar-23 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19
Continuing Operations          
Revenue 6,951.00 7,190.00 7,418.00 7,418.00 7,661.00
Operating Profit/(Loss) 2,082.00 2,293.00 1,693.00 1,693.00 1,428.00
Profit Before Tax 1,907.00 2,094.00 1,518.00 1,518.00 1,295.00
Profit After Tax 1,631.00 1,771.00 1,260.00 1,260.00 985.00
Discontinued Operations          
Profit After Tax n/a 396.00 n/a n/a n/a
PROFIT FOR THE PERIOD 1,631.00 2,167.00 1,260.00 1,260.00 985.00
           
Continuing EPS          
Earnings per Share - Basic 36.80p 37.30p 21.50p 21.50p 16.80p
Earnings per Share - Diluted 36.50p 36.90p 21.30p 21.30p 16.70p
Earnings per Share - Adjusted 37.00p 32.30p 22.90p 22.90p 30.10p
Continuing and Discontinued EPS          
Earnings per Share - Basic 36.80p 37.30p 21.50p 21.50p 16.80p
Earnings per Share - Diluted 36.50p 36.90p 21.30p 21.30p 16.70p
Earnings per Share - Adjusted 37.00p 32.30p 22.90p 22.90p 30.10p
Dividend per Share 14.00p 17.50p 19.00p 19.00p 19.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Mar-23 31-Mar-22 31-Mar-21 31-Mar-20 31-Mar-19
Total Non-Current Assets 38,877.00 39,377.00 59,555.00 60,429.00 44,841.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 58,596.00 60,146.00 78,079.00 79,103.00 62,365.00
Total Liabilities 47,284.00 50,050.00 57,069.00 57,761.00 58,994.00
Net Assets 11,312.00 10,096.00 21,010.00 21,342.00 3,371.00
           
Shareholders Funds 11,820.00 10,598.00 14,865.00 15,055.00 4,014.00
Minority Interests/Other Equity (508.00) (502.00) 6,145.00 6,287.00 (643.00)
Total Equity 11,312.00 10,096.00 21,010.00 21,342.00 3,371.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page